Bridging Functional and Structural Cardiotoxicity Assays Using Human Embryonic Stem Cell-Derived Cardiomyocytes for a More Comprehensive Risk Assessment.
about
Multi-Organ toxicity demonstration in a functional human in vitro system composed of four organs.Morphometric Characterization of Rat and Human Alveolar Macrophage Cell Models and their Response to Amiodarone using High Content Image Analysis.On-chip, multisite extracellular and intracellular recordings from primary cultured skeletal myotubes.Modeling Doxorubicin-Induced Cardiotoxicity in Human Pluripotent Stem Cell Derived-CardiomyocytesSalvianolic Acid A, as a Novel ETA Receptor Antagonist, Shows Inhibitory Effects on Tumor in VitroStem Cells in Neurotoxicology/Developmental Neurotoxicology: Current Scenario and Future Prospects.Simultaneous electrical recording of cardiac electrophysiology and contraction on chip.Cardiac Non-myocyte Cells Show Enhanced Pharmacological Function Suggestive of Contractile Maturity in Stem Cell Derived Cardiomyocyte Microtissues.Frequency-Dependent Multi-Well Cardiotoxicity Screening Enabled by Optogenetic Stimulation.Chronic drug-induced effects on contractile motion properties and cardiac biomarkers in human induced pluripotent stem cell-derived cardiomyocytes.β1-adrenoceptor Arg389Gly polymorphism confers differential β-arrestin-binding tropism in cardiac myocytes.Multielectrode Array (MEA) Assay for Profiling Electrophysiological Drug Effects in Human Stem Cell-Derived Cardiomyocytes.On-chip spatiotemporal electrophysiological analysis of human stem cell derived cardiomyocytes enables quantitative assessment of proarrhythmia in drug development
P2860
Q27300308-513EF01F-9C65-4205-8921-2A09224DAE8DQ30313151-8517ABAC-30E2-472C-B2F1-CF3730C52A69Q30827534-EC5F078E-D25C-4501-BA60-8FED37593EFFQ36864827-9CA5F1F0-0DD0-415A-9CD1-B7F2A6F8E90EQ37209951-6CF0075C-9E85-4C70-9825-E772353605E3Q38669057-39608204-73CD-449F-A46A-1224669F94FEQ38817337-66AB0251-8352-4181-8C74-EBDFDFCBD15BQ39812568-3D647B41-DE44-4C00-BE42-CC92CD869CF9Q47278228-E03C4917-BE63-4B92-9835-07F00BDEFD9BQ48353831-99ACECDC-1984-4C88-8726-37A625008CB1Q51490785-CF3AC689-E2DB-4182-8171-784F04387FD1Q54327084-04733C9C-E3CB-4526-8A51-6F115CF9FA13Q59126210-4B5ED627-1228-4101-BF89-944B12178D92
P2860
Bridging Functional and Structural Cardiotoxicity Assays Using Human Embryonic Stem Cell-Derived Cardiomyocytes for a More Comprehensive Risk Assessment.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Bridging Functional and Struct ...... Comprehensive Risk Assessment.
@en
type
label
Bridging Functional and Struct ...... Comprehensive Risk Assessment.
@en
prefLabel
Bridging Functional and Struct ...... Comprehensive Risk Assessment.
@en
P2093
P2860
P356
P1476
Bridging Functional and Struct ...... Comprehensive Risk Assessment.
@en
P2093
Angela S Williams
Mike Clements
Sian Kalinka
Val Millar
P2860
P304
P356
10.1093/TOXSCI/KFV180
P577
2015-08-10T00:00:00Z